Compare ADMA Biologics Inc (ADMA) vs Core and Main Inc (CNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Core and Main Inc — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while Core and Main Inc trades at $46.35 (market cap $8.73B). The key difference: Core and Main Inc is far larger — about 3.9× ADMA Biologics Inc's market cap. Which is the better fit depends on your goals.
| ADMA | CNM | |
|---|---|---|
Market Cap | $2.22B | $8.73B |
Sector | Health | Technology |
52-Week High | $20.38 | $66.98 |
52-Week Low | $7.60 | $42.37 |
Enterprise Value | $2.29B | $11.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Core and Main Inc
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →
